Neuronal voltage-gated N-type (Ca v 2.2) calcium channels are expressed throughout the nervous system and regulate neurotransmitter release and hence synaptic transmission. They are predominantly modulated via G protein-coupled receptor activated pathways, and the well characterized Gbg subunits inhibit Ca v 2.2 currents. Analgesic a-conotoxin Vc1.1, a peptide from predatory marine cone snail venom, inhibits Ca v 2.2 channels by activating pertussis toxin-sensitive G i/o proteins via the GABA B receptor (GABA B R) and potently suppresses pain in rat models. Using a heterologous GABA B R expression system, electrophysiology, and mutagenesis, we showed a-conotoxin Vc1.1 modulates Ca v 2.2 via a different pathway from that of the GABA B R agonists GABA and baclofen. In contrast to GABA and baclofen, Vc1.1 changes Ca v 2.2 channel kinetics by increasing the rate of activation and shifting its halfmaximum inactivation to a more hyperpolarized potential. We then systematically truncated the GABA B1a C terminus and discovered that removing the proximal carboxyl terminus of the GABA B1a subunit significantly reduced Vc1.1 inhibition of Ca v 2.2 currents. We propose a novel mechanism by which Vc1.1 activates GABA B R and requires the GABA B1a proximal carboxyl terminus domain to inhibit Ca v 2.2 channels. These findings provide important insights into how GABA B Rs mediate Ca v 2.2 channel inhibition and alter nociceptive transmission.